SCHEMBL8380699

SCHEMBL8380699

COc1ccc(-c2sc3cc(OC)ccc3c2Oc2ccc(SO)cc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB4A P04350 2/20 0.66
TUBB P07437 2/20 0.66
TUBA3C P0DPH7 2/20 0.66
TUBA1B P68363 2/20 0.66
TUBA4A P68366 2/20 0.66
TUBB4B P68371 2/20 0.66
TUBB3 Q13509 2/20 0.66
TUBB2A Q13885 2/20 0.66
TUBB8 Q3ZCM7 2/20 0.66
TUBA3E Q6PEY2 2/20 0.66
TUBA1A Q71U36 2/20 0.66
TUBA1C Q9BQE3 2/20 0.66
TUBB6 Q9BUF5 2/20 0.66
TUBB2B Q9BVA1 2/20 0.66
TUBB1 Q9H4B7 2/20 0.66
ESR1 P03372 15/20 0.56
ESR2 Q92731 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.44
UBE2N P61088 1/20 0.44
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16346487 0.86 TUBB4A (0.70) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL21780857 0.84 TUBB4A (0.72) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL28453223 0.83 TUBB4A (0.70) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL18327915 0.83 TUBB4A (0.70) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL15953834 0.83 TUBB4A (0.70) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL14613446 0.81 ESR1 (0.76) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL17155697 0.81 TUBB4A (0.63) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL7499142 0.80 TUBB4A (1.00) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL15954069 0.79 ESR1 (0.86) ESR1
SCHEMBL15954071 0.79 ESR1 (0.86) ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5981765-A FOR TREATMENT OF POST-MENOPAUSAL SYNDROME INCLUDING OSTEOPOROSIS, CARDIOVASCULAR EFFECTS SUCH AS HYPERLIPIDEMIA, AND ESTROGEN-DEPENDENT CANCER, PARTICULARLY BREAST AND UTERINE CANCER ELI LILLY AND COMPANY (US) 1999-11-09 US disclosed
US-5919800-A INHIBITING ENDOMETRIOSIS BY ADMISTERING (6-HYDROXY-3-(4-(2-(1-PIPERIDINYL)ETHOXY)PHENOXY)-2-(4-METHOXYPHENYL))BENZO B)THIOPHENE OR THE HYDROCHLORIDE SALT THEREOF ELI LILLY AND COMPANY (US) 1999-07-06 US disclosed
US-5856339-A POST-MENOPAUSAL SYNDROME, AND UTERINE FIBROID DISEASE, ENDOMETRIOSIS, AND AORTAL SMOOTH MUSCLE CELL PROLIFERATION. ELI LILLY AND COMPANY (US) 1999-01-05 US disclosed
US-5856340-A 2-PHENYL-3-/ALKOXYPHENOXY OR PHENYLTHIO/BENZOTHIOPHENES ELI LILLY AND COMPANY (US) 1999-01-05 US disclosed
US-5723474-A TREATING POST-MENOPAUSAL SYNDROME, UTERINE FIBROID DISEASE, ENDOMETRIOSIS, AND AORTAL SMOOTH MUSCLE CELL PROLIFERATION; ANTIESTROGENS ELI LILLY AND COMPANY (US) 1998-03-03 US disclosed
US-5510357-A POST-MENOPAUSAL SYNDROME, ENDOMETRIOSIS ELI LILLY AND COMPANY (US) 1996-04-23 US disclosed
US-5510358-A OSTEOPOROSIS ELI LILLY AND COMPANY (US) 1996-04-23 US disclosed
US-5510498-A Benzothiophene compounds, intermediates, compositions, and methods ELI LILLY AND COMPANY (US) 1996-04-23 US disclosed